Pursuing progress in acute coronary syndromes.

The sheer scope of the burden of acute ischemic heart disease, initially evident in Western civilization but now increasingly a global problem, places a high priority on understanding its pathophysiology and identifying individuals at increased risk of morbid and mortal events. So too is there strong impetus for the timely development and introduction of cost-effective therapeutic solutions coupled with concurrent strategies for both primary and secondary prevention.